Endometrial cancer is typically endometrioid adenocarcinoma.While endometrial adenocarcinoma is a very common gynecologic malignancy in the U.S., it has a promising prognosis since most women present with symptoms at an early stage; 4% of cancer deaths in women result from endometrial adenocarcinomaThe ACS estimates that in 2017, 61,380 new cases of endometrial cancer will be diagnosed and 10,920 women will die from the disease.